Showing results (41-50 of 133) with videos related to
Sort By:
Pageof 14
Journal of Neurosurgery|January 11, 2011
Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomographyNatsuki Shinozaki, Yoshio Uchino, Kyosan Yoshikawa, et al.Oncotarget|July 3, 2018
Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastomaMasaki Yoshioka, Tomoo Matsutani, Ayaka Hara, et al.Anticancer Research|April 4, 2008
High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomasYasuo Iwadate, Masayo Hayama, Akihiko Adachi, et al.Journal of Neurosurgery|December 1, 2006
Gamma Knife surgery for metastatic brain tumors without prophylactic whole-brain radiotherapy: results in 1000 consecutive casesToru Serizawa, Yoshinori Higuchi, Junichi Ono, et al.Scientific Reports|July 16, 2021
Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center studySeiichiro Hirono, Ko Ozaki, Masayoshi Kobayashi, et al.Cancer Research|April 3, 2004
Molecular classification and survival prediction in human gliomas based on proteome analysisYasuo Iwadate, Tsukasa Sakaida, Takaki Hiwasa, et al.World Neurosurgery|April 8, 2019
Mechanism of Corpus Callosum Infarction Associated with Acute Hydrocephalus: Clinical, Surgical, and Radiological Evaluations for PathophysiologySeiichiro Hirono, Daisuke Kawauchi, Masayoshi Kobayashi, et al.Journal of Neuro-Oncology|April 26, 2015
Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphomaSeiichiro Hirono, Yasuo Iwadate, Yoshinori Higuchi, et al.International Journal of Oncology|March 9, 2005
Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomasYasuo Iwadate, Tsukasa Sakaida, Takashi Saegusa, et al.Journal of Experimental & Clinical Cancer Research : CR|October 12, 2012
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomasTomoo Matsutani, Takaki Hiwasa, Masaki Takiguchi, et al.Pageof 14